Exelixis
EXEL
#1718
Rank
NZ$21.18 B
Marketcap
NZ$84.27
Share price
-1.89%
Change (1 day)
16.95%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company